14159 capital gp llc - through partnership investment history in Ap pharma inc de

Filed on 2011-04-26 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-11-024144.txt Sec File: edgar/data/1317493/0001144204-11-024144-index.htm

2011-04-24 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Ap Pharma Inc De bought 10800 shares at $0 remaining shares owned 10800

Rights To Purchase Senior Secured Convertible Notes Due 2021 Ap Pharma Inc De Appa exercise price 1000 has valueunderlying security shares 10800 underlying security title Senior Secured Convertible Notes Due 2021

f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are controlling members of 14159 capital (gp), llc.
f8 the exercise price to purchase the senior secured convertible notes due 2021 represented by the rights is $1,000 for each $1,000 principal amount of the senior secured convertible notes due 2011 purchased upon exercise.
f4 the closing date of the purchase of the senior secured convertible notes due 2021.
f6 the date that is 2 years following the closing date of the purchase of the senior secured convertible notes due 2021.
f9 the senior secured convertible notes due 2021 underlying the rights are convertible, at a conversion price of $0.04 per share, into an aggregate of 270,000 shares of common stock of the issuer.
f7 14159, l.p. does not have the right to convert any portion of any senior secured convertible notes due 2021, to the extent that after giving effect to such conversion, 14159, l.p. (together with its affiliates) would beneficially own in excess of 9.99% (subject to change as described in the note) of the number of shares of common stock outstanding immediately after giving effect to such conversion.


Filed on 2011-04-26 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 4

Accession 0001144204-11-024144.txt Sec File: edgar/data/1317493/0001144204-11-024144-index.htm

2011-04-24 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Ap Pharma Inc De bought 5400 shares at $5400 remaining shares owned 5400

Senior Secured Convertible Notes Due 2021 Ap Pharma Inc De Appa exercise price 0.04 has valueunderlying security shares 135000 underlying security title Common Stock

f1 in addition to 14159 capital (gp), llc, this form 4 is being filed jointly by julian c. baker and felix j. baker, each of whom has the same business address as 14159 capital (gp), llc and may be deemed to have a pecuniary interest in securities owned by it. because of certain relationships with other security holders of the issuer, the reporting persons are filing solely for informational purposes as if they were a member of a group of such shareholders. (continued in footnote 2).
f2 however, the reporting persons disclaim that they and any other person or persons, in fact constitute a "group" for purposes of section 13(d)(3) of the securities exchange act of 1934, as amended, or rule 13d-5 thereunder or that they are the beneficial owners of securities owned by any such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
f3 represents securities owned directly by 14159, l.p., the sole general partner of which is 14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp),llc. julian c. baker and felix j. baker are controlling members of 14159 capital (gp), llc.
f4 the closing date of the purchase of the senior secured convertible notes due 2021.
f5 the date that is 10 years following the closing date of the purchase of the senior secured convertible notes due 2021.
f7 14159, l.p. does not have the right to convert any portion of any senior secured convertible notes due 2021, to the extent that after giving effect to such conversion, 14159, l.p. (together with its affiliates) would beneficially own in excess of 9.99% (subject to change as described in the note) of the number of shares of common stock outstanding immediately after giving effect to such conversion.


Filed on 2009-10-28 by 14159 Capital (Gp), Llc SEC CIK 1317493 Form 3

Accession 0001144204-09-055184.txt Sec File: edgar/data/1317493/0001144204-09-055184-index.htm

2009-10-19 14159 Capital Gp Llc (CIK 1317493) through Through Partnership

Invested in Ap Pharma Inc De remaining shares owned 156591

Common Stock Ap Pharma Inc De Appa

f1 this form 3 is filed on behalf of a group consisting of 14159 capital (gp), llc, julian c. baker and felix j. baker. thereporting persons are filing solely for informational purposes as if they were members of a group of such shareholders. thereporting persons disclaim that they and any other person or persons in fact constitute a "group" for purposes of section13(d)(3) of the securities exchange act of 1934, as amended (the "exchange act"), or rule 13d-5 thereunder.
f2 as the sole general partner of 14159 capital, l.p., 14159 capital (gp), llc may be deemed to be the indirect beneficial ownerof such securities under rule 16a-1(a)(2) promulgated under the exchange act. however, pursuant to rule 16a-1(a)(4)promulgated under the exchange act, 14159 capital (gp), llc disclaims beneficial ownership of such securities, except to theextent of its pecuniary interest therein. as the controlling members of 14159 capital (gp), llc, julian c. baker and felixj. baker may be deemed to be the indirect beneficial owners of such securities under rule 16a-1(a)(2) promulgated under theexchange act. however, pursuant to rule 16a-1(a)(4) promulgated under the exchange act, each of julian c. baker and felix j.baker disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.
f3 the securities of the issuer are owned directly by 14159, l.p., a limited partnership the sole general partner of which is14159 capital, l.p., a limited partnership the sole general partner of which is 14159 capital (gp), llc. julian c. baker andfelix j. baker are the controlling members of 14159 capital (gp), llc. 14159 capital (gp), llc, julian c. baker and felix j.baker may have indirect beneficial ownership of these securities. see footnotes 1 and 2.